Latest news

Eye injection drugs recommended by NICE cost the NHS up to £447 million annually, but could be replaced by an unlicensed drug, bevacizumab, costing as much as ten times less.

The city’s heroes of healthcare were recognised at a sparkling event hosted by the Bristol Post on Wednesday 25 October 2017.

A major international study has pinpointed more than 100 genetic risk factors that explain why some people suffer from asthma, hay fever and eczema.

Around 1,000 children are born with cleft lip and/or palate in the UK each year, with many children requiring long-term multi-disciplinary care.

An additional 20 minutes of commuting each working day is equivalent to a 19% annual pay cut when it comes to measuring how satisfied people say they are with their jobs, a new study has found.

Two recent studies led by the University of Bristol provide significant new hope in the fight against antibiotic resistance.

Kidney failure is associated with lower quality of life in young people and limited employment, independence, and relationships compared with healthy peers.

Hospital trusts across the country are being urged to use an initiative developed in Bristol to improve patient safety in emergency departments.

Developed in maternity units across the West of England, the ‘PReCePT’ project has been selected by the Health Foundation to be part of an ambitious £3.5 million improvement programme.

A new Health Integration Team (HIT) focused on stroke has been given the go-ahead by the Bristol Health Partners executive group. Stroke HIT aims to advance and improve the prevention of strokes and care for stroke patients.

powered by Hummingbird CMS